Coronaridine congeners attenuate fentanyl seeking during prolonged abstinence

Keyphrases

• Fentanyl 100%
• Coronaridine Congeners 100%
• Prolonged Abstinence 100%
• 18-Methoxycoronaridine 87%
• Catharanthine 87%
• Dopamine Release 50%
• Opioid Use Disorder 50%
• Nucleus Accumbens 37%
• Vapor Injection 37%
• Fast-scan Cyclic Voltammetry 37%
• Self-administer 25%
• Overdose Deaths 25%
• Cue-induced Drug Seeking 25%
• Record-breaking 25%
• Opioids 12%
• μ-opioid Receptor 12%
• Molecular Mechanism 12%
• Nicotinic Acetylcholine Receptor (nAChR) 12%
• Psychiatric Illness 12%
• Crossover Design 12%
• Presynaptic Terminal 12%
• C57BL 12%
• Drugs of Abuse 12%
• Inhalation 12%
• Drug Cues 12%
• Consecutive Days 12%
• Abstinence 12%
• Home Cage 12%
• Anti-addiction 12%
• Anxiolytic Activity 12%
• Antidepressants 12%
• Tight 12%
• Vaping 12%
• Pharmaceutics 12%
• Self-administration 12%
• Pharmacological Therapy 12%
• Cue-induced 12%
• Drug Bioavailability 12%
• Extinction Condition 12%
• Abstinence Rate 12%
• Self-administration Model 12%
• Operant Chamber 12%
• Forced Abstinence 12%
• Current Needs 12%
• Day off 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Duragesic 100%
• Coronaridine 100%
• 18 Methoxycoronaridine 77%
• Catharanthine 77%
• Opiate 66%
• Disease 55%
• Toxic Injury 22%
• N [2 (2 Methoxyphenyl)acetyl]dehydroalanine 22%
• Prevalence 11%
• Dopamine Receptor Stimulating Agent 11%
• Bioavailability 11%
• Antidepressant 11%
• C57BL 6 Mouse 11%
• Nicotinic Acetylcholine Receptor Antagonist 11%